Cite
Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
MLA
Wang C, et al. “Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multicenter, Controlled Trial.” CHEST, vol. 137, no. 2, Feb. 2010, pp. 254–62. EBSCOhost, https://doi.org/10.1378/chest.09-0765.
APA
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH, China Venous Thromboembolism (VTE) Study Group, Wang, C., Zhai, Z., Yang, Y., Wu, Q., Cheng, Z., Liang, L., & Dai, H. (2010). Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. CHEST, 137(2), 254–262. https://doi.org/10.1378/chest.09-0765
Chicago
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, et al. 2010. “Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multicenter, Controlled Trial.” CHEST 137 (2): 254–62. doi:10.1378/chest.09-0765.